IRCT20180909040978N1
Completed
Phase 3
Evaluation of clinical and dermoscopic effects of topical use of KOH 5% solution on Actinic Keratosis and its comparison with 5-Fluorouracil topical cream on patients suffering Actinic Keratosis.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Actinic Keratosis.
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients suffering Actinic Keratosis attending Razi dermotology hospital
- •Having at least 18 years of age
- •Having a minimum number of 8 lesions( 4 on each side, at least) on parts of skin that are exposed to the sun.
Exclusion Criteria
- •Pregnant women
- •People with a history of allergy to any of the drugs under study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Comparision of two treatment modalities for patchy hair lossHealth Condition 1: null- alopecia areataCTRI/2016/08/007218AKSHMI KANTH MALLADI40
Completed
Phase 2
Treatment of common warts with topical solution of potassium hydroxide 15%Common wart.Verruca VulgarisIRCT2014081118765N1Ahvaz Jundishapur University of Medical Sciences, Vice Chancellor29
Recruiting
Not Applicable
Clinico-pathological study on the effectiveness of cepharanthin on the prevention of destruction of acinar structure in Sjogren's syndrome patientsSjogren's syndromeJPRN-UMIN000005878Department of Oral Medicine, Institute of Health Biosciences, The University of Tokushima Graduate Faculty of Dentistry10
Completed
Not Applicable
A study on the dermatological efficacy of physical therapy for healthy skiHealthy adultsJPRN-UMIN000019923Kao Corporation30
Recruiting
Not Applicable
Photography and measuring blood level of markers in patients with patchy hair lossCTRI/2018/02/011856I